This report sustained the role of CTLA-4 as a regulator of T-cell activation and immune tolerance and highlighted that CTLA-4 pathway alteration can lead to inflammatory demyelination, thus having significant implications for the development of new possible treatments for autoimmune disorders such as MS [154]. The gene discussed is CTLA4; the disease is Autoimmunity.